1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Targeting the Wnt/beta-catenin pathway in multiple myeloma.

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent investigations have shown that the Wnt signaling pathway is constitutively activated in multiple myeloma (MM), thereby promoting an exaggerated cell proliferation. Thus, influencing the Wnt pathway might represent a promising target in myeloma treatment.

          Related collections

          Author and article information

          Journal
          Anticancer Res.
          Anticancer research
          1791-7530
          0250-7005
          Nov 2013
          : 33
          : 11
          Affiliations
          [1 ] Department of Internal Medicine III, Center for Integrated Oncology (CIO), University Hospital Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany. Ingo.Schmidt-Wolf@ukb.uni-bonn.de.
          Article
          33/11/4719
          24222106
          940bcd2e-b3af-42ec-af8d-d9348a2791f6
          History

          OPM-2,RPMI-8226,U-266 cell lines,Wnt inhibitors,Wnt pathway,beta-catenin,signaling therapies,MPC-11,Myeloma

          Comments

          Comment on this article